BioLineRx Ltd. - American Depositary Shares (BLRX)

Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

BioLineRx shares new data from its Phase 2 pancreatic cancer trial, showing strong response rates and durable outcomes with motixafortide combination.

The company said that updated results from the pilot phase indicate that four of eleven patients remained disease progression-free after more than one year.

CEO Philip Serlin said that the company has been actively evaluating new assets in the areas of oncology and rare diseases, where it can leverage its expertise after out-licensing Aphexda.

Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.